<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-044963</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Postoperative analgesia in cardiac surgery: spinal versus intravenous morphine</dc:title>
<dc:description xml:lang="en">OBJETIVE: To compare the effects of spinal and intravenousadministration of morphine to supplement anesthesiawith remifentanil in terms of analgesia during early postoperativerecovery and considering time until extubation.MATERIAL AND METHODS: This prospective, randomized,blinded trial enrolled 59 patients scheduled for cardiac surgery.The patients were assigned to receive either a spinalinfusion of morphine (15 µg·Kg-1) or an intravenous infusion(0.3 mg·Kg-1). Anesthesia was maintained with 0.15 to 0.50µg·Kg-1·min-1 of remifentanil and 2 to 4 mg·Kg-1·h-1 of propofolin perfusion. After the period of extracorporeal circulation,all patients were given an intravenous infusion of 30 mgof ketorolac. Later intravenous ketorolac was ministered at adose of 30 mg per 8 hours; intravenous morphine (bolus doseof 3 mg) was also administered until pain was relieved.RESULTS: The same quality of postoperative analgesiaand anesthetic recovery was achieved with both spinal andintravenous administration. The incidence of side effectswas also similar. Likewise, the extubation times were similarin the 2 groups (spinal infusion group: 294.5 [SD,150.5] minutes; intravenous group: 325.0 [139.9] minutes;P&gt;0.05). Less postoperative intravenous morphine wasadministered in the first 24 hours to patients in the spinalmorphine group (P&lt;0.05) and fewer patients in that grouprequired intravenous morphine boluses (P&lt;0.05).CONCLUSIONS: Our study suggests that spinal morphinedoes not offer advantages over intravenous morphinewith regard to postoperative analgesia, hemodynamicstability and respiratory parameters, time until extubation,or adverse effects</dc:description>
<dc:creator>Soria, S</dc:creator>
<dc:creator>Castrodeza, J</dc:creator>
<dc:creator>Tamayo, E</dc:creator>
<dc:creator>Rodríguez, R</dc:creator>
<dc:creator>Muñoz, F</dc:creator>
<dc:creator>Martínez-Martínez, A</dc:creator>
<dc:creator>Ruiz de Temiño, F</dc:creator>
<dc:creator>Lajo, B</dc:creator>
<dc:creator>Martínez-Escribano, A</dc:creator>
<dc:creator>Olmedo, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">OBJETIVOS: Comparar, en pacientes intervenidos decirugía cardiaca, el efecto de la morfina intratecal (IT)frente a la morfina intravenosa (IV), como suplemento ala anestesia con remifentanilo. Se valoran el tiempo deextubación y la analgesia durante el postoperatorio inmediato.MATERIAL Y MÉTODOS: Estudio prospectivo, randomizadoy ciego, en el que se incluyen 59 pacientes programadospara cirugía cardiaca. Los pacientes fueron asignadosal grupo MIT (15 µg Kg-1 de morfina intratecal) oal grupo MIV (0,3 mg Kg-1 de morfina intravenosa). Laanestesia fue mantenida con 0,15-0,50 µg Kg-1min-1 deremifentanilo y 2-4 mg Kg-1h-1 de propofol en perfusión.Después del periodo de circulación extracorpórea, atodos se les administró 30 mg IV de ketorolaco. Posteriormentese administró ketorolaco IV (30 mg/8 horas) ybolus de morfina IV de 3 mg hasta el alivio del dolor.RESULTADOS: Con las dos pautas analgésicas (morfinaIT y morfina IV) se alcanzó el mismo nivel de analgesiapostoperatoria, recuperación anestésica y efectos secundarios.Los tiempos de extubación fueron similares en losdos grupos (Grupo MIT: 294,5 ± 150,5 minutos; grupoMIV: 325,0 ± 139,9 minutos, p &lt; 0,05). La dosis de morfinaIV administrada durante las primeras 24 horas fuemenor (p&lt;0,05) en el grupo MIT, en este grupo menospacientes precisaron bolos de morfina IV (p&lt;0,05).CONCLUSIONES: Nuestro estudio sugieren que la morfinaIT no ofrece ventajas sobre la administración de morfinaIV con respecto a la analgesia postoperatoria, parámetroshemodinámicos y respiratorios, tiempo deextubación o efectos adversos</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;53(3): 145-151, mar. 2006. tab</dc:source>
<dc:identifier>ibc-044963</dc:identifier>
<dc:title xml:lang="es">Analgesia postoperatoria en cirugía cardíaca: comparación de morfina intratecal versus morfina intravenosa</dc:title>
<dc:subject>^d29646</dc:subject>
<dc:subject>^d19283</dc:subject>
<dc:subject>^d6500</dc:subject>
<dc:subject>^d19390</dc:subject>
<dc:subject>^d715^s22000</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9211^s22000</dc:subject>
<dc:subject>^d715^s22073</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d10336^s22057</dc:subject>
<dc:subject>^d9211^s22073</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d4419</dc:subject>
<dc:subject>^d19613</dc:subject>
<dc:subject>^d24877</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d27938^s22000</dc:subject>
<dc:subject>^d34399^s22000</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d7450</dc:subject>
<dc:subject>^d18001</dc:subject>
<dc:type>article</dc:type>
<dc:date>200603</dc:date>
</metadata>
</record>
</ibecs-document>
